Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) and a BRCA mutation (BRCAm).
作者： Jonathan A. Ledermann , Philipp Harter , Charlie Gourley , Michael Friedlander , Ignace Vergote
DOI: 10.1200/JCO.2013.31.15_SUPPL.5505
关键词:
摘要: 5505 Background: Previously, we reported that maintenance treatment with the oral PARP inhibitor olaparib (400 mg bid) led to a significant PFS improvement vs placebo in patients (pts) platinu...
sci-hub.st 参考文章(0)